Company / Net Debt per Share
FATE THERAPEUTICS INC Net Debt per Share History
FY2016-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$1.45
FY2018
5-year range
-
FY2016-FY2018
Trend
+18.5%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $-2.17 to $-1.45 over the past 2 years.
Based on SEC 10-K filings.
-1.45 in FY2018.
Increased from $-2.17 to $-1.45 over the past 2 years.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2018, net debt per share increased 18.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 632.81 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | -$1.45 | +18.5% |
| FY2017 | -$1.78 | +17.8% |
| FY2016 | -$2.17 | -3.0% |
As of FY2018 · SEC 10-K · Updated Jun 24, 2026